Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)
Close on Nov 13, 2026Market cap $359.12MP/E –Yield –
Tilray Brands total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Tilray Brands's total debt was $126.73M at Aug 31, 2026. For fiscal 2026 it was $129.20M, up 1699.2% from the year before. The highest annual figure on record is $203.83M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | $129.20M | +1699.2% |
| FY2025 | May 31, 2025 | $7.18M | -60.2% |
| FY2024 | May 31, 2024 | $18.03M | -22.9% |
| FY2023 | May 31, 2023 | $23.38M | -88.5% |
| FY2022 | May 31, 2022 | $203.83M | +2061.0% |
| FY2017 | Dec 31, 2017 | $9.43M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | $126.73M | +1448.4% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | $129.20M | +1699.2% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | $8.83M | -50.2% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | $8.57M | -52.8% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | $8.19M | -54.6% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | $7.18M | -52.2% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | $17.75M | -12.0% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | $18.13M | +24.3% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | $18.03M | -22.9% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | $15.03M | -17.1% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | $20.18M | +31.9% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | $14.59M | -82.3% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | $23.38M | -88.5% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | $18.13M | -91.3% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | $15.30M | -92.0% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | $82.38M | -59.8% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | $203.83M | +2080.4% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | $208.88M | +2188.4% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | $192.07M | +1936.3% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | $204.95M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | $9.35M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | $9.13M | – |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | $9.43M | – |
See a number that looks wrong?